Autologous BCMA-targeted CAR-T Cell Injection for Relapsed/Refractory Light Chain Amyloidosis
Clinical trial NCT07626476 · RECRUITING
Trial details
- NCT number
- NCT07626476
- Sponsor
- Beijing Boren Hospital
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-16
- Primary completion
- 2027-12-15
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.